BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30109666)

  • 21. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss.
    Nannipieri M; Cecchetti F; Anselmino M; Camastra S; Niccolini P; Lamacchia M; Rossi M; Iervasi G; Ferrannini E
    Int J Obes (Lond); 2009 Sep; 33(9):1001-6. PubMed ID: 19636322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass.
    Lin E; Davis SS; Srinivasan J; Sweeney JF; Ziegler TR; Phillips L; Gletsu-Miller N
    Am Surg; 2009 Jun; 75(6):498-502; discussion 502-3. PubMed ID: 19545098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery.
    Trakhtenbroit MA; Leichman JG; Algahim MF; Miller CC; Moody FG; Lux TR; Taegtmeyer H
    Am J Med; 2009 May; 122(5):435-42. PubMed ID: 19375553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass.
    Elahi D; Galiatsatos P; Rabiee A; Salas-Carrillo R; Vakilipour A; Carlson OD; Angeli FS; Shannon RP; Egan JM; Andersen DK
    Surg Obes Relat Dis; 2014; 10(6):1028-39. PubMed ID: 25443077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carotid intima-media thickness is reduced 12 months after gastric bypass surgery in obese patients with type 2 diabetes or impaired glucose tolerance.
    Lundby-Christensen L; Tarnow L; Hansen DL; Worm D; Naver LS; Hvolris LE; Wiinberg N; Vaag A; Almdal TP
    J Diabetes Complications; 2014; 28(4):517-22. PubMed ID: 24685364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early reduction of resting energy expenditure and successful weight loss after Roux-en-Y gastric bypass.
    Moehlecke M; Andriatta Blume C; Rheinheimer J; Trindade MRM; Crispim D; Leitão CB
    Surg Obes Relat Dis; 2017 Feb; 13(2):204-209. PubMed ID: 27692914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fatty acid profile of adipose tissue as a predictor of the ponderal and inflammatory response in adult women six years after bariatric surgery.
    Almeida CDG; Viana EC; Moreira AVB; Miguel GPS; Pedra FSG; Oliveira FE; Quimquim TN; Bissoli NS; Alves RDM; Bressan J
    Lipids Health Dis; 2020 Mar; 19(1):45. PubMed ID: 32178673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline Anthropometric and Metabolic Parameters Correlate with Weight Loss in Women 1-Year After Laparoscopic Roux-En-Y Gastric Bypass.
    Sans A; Bailly L; Anty R; Sielezenef I; Gugenheim J; Tran A; Gual P; Iannelli A
    Obes Surg; 2017 Nov; 27(11):2940-2949. PubMed ID: 28550439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roux-en-Y Gastric Bypass Is More Effective than Sleeve Gastrectomy in Improving Postprandial Glycaemia and Lipaemia in Non-diabetic Morbidly Obese Patients: a Short-term Follow-up Analysis.
    Liaskos C; Koliaki C; Alexiadou K; Argyrakopoulou G; Tentolouris N; Diamantis T; Alexandrou A; Katsilambros N; Kokkinos A
    Obes Surg; 2018 Dec; 28(12):3997-4005. PubMed ID: 30112599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
    Salminen P; Helmiö M; Ovaska J; Juuti A; Leivonen M; Peromaa-Haavisto P; Hurme S; Soinio M; Nuutila P; Victorzon M
    JAMA; 2018 Jan; 319(3):241-254. PubMed ID: 29340676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.
    Robert M; Espalieu P; Pelascini E; Caiazzo R; Sterkers A; Khamphommala L; Poghosyan T; Chevallier JM; Malherbe V; Chouillard E; Reche F; Torcivia A; Maucort-Boulch D; Bin-Dorel S; Langlois-Jacques C; Delaunay D; Pattou F; Disse E
    Lancet; 2019 Mar; 393(10178):1299-1309. PubMed ID: 30851879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: relationship with metabolic outcomes.
    Gómez-Ambrosi J; Andrada P; Valentí V; Rotellar F; Silva C; Catalán V; Rodríguez A; Ramírez B; Moncada R; Escalada J; Salvador J; Frühbeck G
    Int J Obes (Lond); 2017 Sep; 41(9):1379-1387. PubMed ID: 28584299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
    Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS
    Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline of visceral fat area and decreased body weight correlate with improved pulmonary function after Roux-en-Y gastric bypass in Chinese obese patients with BMI 28-35 kg/m² and type 2 diabetes: a 6-month follow-up.
    Tu Y; Yu H; Bao Y; Zhang P; Di J; Han X; Jia W
    BMC Endocr Disord; 2015 Jun; 15():26. PubMed ID: 26054757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.
    Camastra S; Gastaldelli A; Mari A; Bonuccelli S; Scartabelli G; Frascerra S; Baldi S; Nannipieri M; Rebelos E; Anselmino M; Muscelli E; Ferrannini E
    Diabetologia; 2011 Aug; 54(8):2093-102. PubMed ID: 21614570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric bypass simultaneously improves adipose tissue function and insulin-dependent type 2 diabetes mellitus.
    Billeter AT; Vittas S; Israel B; Scheurlen KM; Hidmark A; Fleming TH; Kopf S; Büchler MW; Müller-Stich BP
    Langenbecks Arch Surg; 2017 Sep; 402(6):901-910. PubMed ID: 28691147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery.
    Navaneethan SD; Kelly KR; Sabbagh F; Schauer PR; Kirwan JP; Kashyap SR
    Obes Surg; 2010 Mar; 20(3):308-15. PubMed ID: 20217955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.
    Rubino F; Gagner M; Gentileschi P; Kini S; Fukuyama S; Feng J; Diamond E
    Ann Surg; 2004 Aug; 240(2):236-42. PubMed ID: 15273546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in subcutaneous fat cell volume and insulin sensitivity after weight loss.
    Andersson DP; Eriksson Hogling D; Thorell A; Toft E; Qvisth V; Näslund E; Thörne A; Wirén M; Löfgren P; Hoffstedt J; Dahlman I; Mejhert N; Rydén M; Arner E; Arner P
    Diabetes Care; 2014 Jul; 37(7):1831-6. PubMed ID: 24760260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.